交易 BioAtla, Inc. - BCAB CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.05 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Bioatla Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 2.98 | 0.09 | 3.11% | 2.89 | 3.02 | 2.80 |
Jun 28, 2022 | 2.95 | -0.03 | -1.01% | 2.98 | 3.05 | 2.85 |
Jun 27, 2022 | 3.03 | -0.45 | -12.93% | 3.48 | 3.49 | 2.94 |
Jun 24, 2022 | 3.50 | 0.36 | 11.46% | 3.14 | 3.51 | 3.01 |
Jun 23, 2022 | 2.98 | 0.04 | 1.36% | 2.94 | 2.99 | 2.80 |
Jun 22, 2022 | 2.92 | 0.31 | 11.88% | 2.61 | 2.99 | 2.60 |
Jun 21, 2022 | 2.71 | -0.16 | -5.57% | 2.87 | 2.87 | 2.58 |
Jun 17, 2022 | 2.59 | 0.09 | 3.60% | 2.50 | 2.73 | 2.47 |
Jun 16, 2022 | 2.45 | -0.10 | -3.92% | 2.55 | 2.59 | 2.41 |
Jun 15, 2022 | 2.63 | 0.07 | 2.73% | 2.56 | 2.71 | 2.56 |
Jun 14, 2022 | 2.65 | -0.01 | -0.38% | 2.66 | 2.72 | 2.56 |
Jun 13, 2022 | 2.64 | -0.17 | -6.05% | 2.81 | 2.85 | 2.55 |
Jun 10, 2022 | 2.92 | -0.19 | -6.11% | 3.11 | 3.25 | 2.84 |
Jun 9, 2022 | 3.01 | 0.08 | 2.73% | 2.93 | 3.07 | 2.89 |
Jun 8, 2022 | 3.02 | 0.07 | 2.37% | 2.95 | 3.08 | 2.93 |
Jun 7, 2022 | 3.06 | 0.48 | 18.60% | 2.58 | 3.07 | 2.58 |
Jun 6, 2022 | 2.66 | 0.08 | 3.10% | 2.58 | 2.79 | 2.58 |
Jun 3, 2022 | 2.72 | 0.43 | 18.78% | 2.29 | 2.74 | 2.29 |
Jun 2, 2022 | 2.39 | 0.14 | 6.22% | 2.25 | 2.45 | 2.24 |
Jun 1, 2022 | 2.31 | -0.09 | -3.75% | 2.40 | 2.47 | 2.26 |
BioAtla, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Wednesday, June 14, 2023 | ||
时间(协调世界时) (UTC) 15:00 | 国家/地区 US
| 事件 Bioatla Inc Annual Shareholders Meeting Bioatla Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 7, 2023 | ||
时间(协调世界时) (UTC) 20:00 | 国家/地区 US
| 事件 Q2 2023 Bioatla Inc Earnings Release Q2 2023 Bioatla Inc Earnings ReleaseForecast -Previous - |
Wednesday, November 1, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q3 2023 Bioatla Inc Earnings Release Q3 2023 Bioatla Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 0 | 0.25 | 0.429 | 5.2 | 10.627 |
收入 | 0 | 0.25 | 0.429 | 5.2 | 10.627 |
总营业费用 | 108.14 | 96 | 33.411 | 33.468 | 38.861 |
销售/一般/行政费用,总计 | 28.793 | 38.416 | 10.595 | 7.549 | 12.556 |
研究与开发 | 79.347 | 58.274 | 19.933 | 25.919 | 26.305 |
异常费用(收入) | 0 | -0.69 | 2.883 | 0 | 0 |
营业收入 | -108.14 | -95.75 | -32.982 | -28.268 | -28.234 |
利息收入(费用),非经营净值 | 1.648 | 0.347 | -2.87 | -1.565 | -0.74 |
其他,净值 | 0.01 | 0.001 | -0.001 | -0.022 | -0.005 |
税前净收入 | -106.482 | -95.402 | -35.853 | -29.855 | -28.979 |
税后净收入 | -106.482 | -95.402 | -35.853 | -29.855 | -28.979 |
少数股东权益 | 0 | 0 | 0.061 | 0 | |
未计算非常项目前的净收益 | -106.482 | -95.402 | -35.853 | -29.794 | -28.979 |
净收入 | -106.482 | -95.402 | -35.853 | -29.794 | -28.979 |
Total Adjustments to Net Income | 1.063 | 0.815 | |||
普通股股东可获收益 (不含非经常性项目) | -106.482 | -95.402 | -35.853 | -28.731 | -28.164 |
普通股股东可获收益 (含非經常性項目) | -106.482 | -95.402 | -35.853 | -28.731 | -28.164 |
摊薄净收入 | -106.482 | -95.402 | -35.853 | -28.731 | -28.164 |
摊薄后加权平均股 | 38.9273 | 34.5612 | 32.0886 | 32.0886 | 32.0886 |
扣除特别项目的每股摊薄盈利 | -2.73541 | -2.76038 | -1.11731 | -0.89536 | -0.87769 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
每股正常摊薄盈利 | -2.73541 | -2.78034 | -1.02747 | -0.89536 | -0.87769 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | |
总营业费用 | 28.93 | 28.56 | 26.179 | 29.055 | 24.346 |
销售/一般/行政费用,总计 | 7.233 | 6.686 | 6.34 | 8.344 | 7.423 |
研究与开发 | 21.697 | 21.874 | 19.839 | 20.711 | 16.923 |
营业收入 | -28.93 | -28.56 | -26.179 | -29.055 | -24.346 |
利息收入(费用),非经营净值 | 1.48 | 1.047 | 0.37 | 0.146 | 0.085 |
税前净收入 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
税后净收入 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
未计算非常项目前的净收益 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
净收入 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
普通股股东可获收益 (不含非经常性项目) | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
普通股股东可获收益 (含非經常性項目) | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
摊薄净收入 | -27.46 | -27.543 | -25.779 | -28.906 | -24.254 |
摊薄后加权平均股 | 47.5784 | 43.4475 | 37.5168 | 37.5403 | 37.3224 |
扣除特别项目的每股摊薄盈利 | -0.57715 | -0.63394 | -0.68713 | -0.77 | -0.64985 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.57715 | -0.63394 | -0.68713 | -0.77 | -0.64985 |
异常费用(收入) | 0 | 0 | |||
其他,净值 | -0.01 | -0.03 | 0.03 | 0.003 | 0.007 |
少数股东权益 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 220.431 | 247.292 | 240.681 | 4.507 | 12.662 |
现金和短期投资 | 215.507 | 244.979 | 238.605 | 3.704 | 10.863 |
现金等价物 | 215.507 | 244.979 | 238.605 | 3.704 | 10.863 |
Prepaid Expenses | 4.924 | 2.313 | 2.076 | 0.803 | 1.799 |
Total Assets | 225.736 | 254.422 | 244.937 | 9.336 | 16.637 |
Property/Plant/Equipment, Total - Net | 5.151 | 6.976 | 4.102 | 4.675 | 3.878 |
Property/Plant/Equipment, Total - Gross | 10.515 | 11.233 | 7.172 | 6.889 | 5.258 |
Accumulated Depreciation, Total | -5.364 | -4.257 | -3.07 | -2.214 | -1.38 |
Other Long Term Assets, Total | 0.154 | 0.154 | 0.154 | 0.154 | 0.097 |
Total Current Liabilities | 23.131 | 19.813 | 32.261 | 26.718 | 9.196 |
Accounts Payable | 4.231 | 1.179 | 2.456 | 5.139 | 1.961 |
Payable/Accrued | 13.928 | 14.574 | 6.808 | 4.536 | 4.866 |
Accrued Expenses | 4.972 | 4.06 | 2.804 | 5.55 | 1.864 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 9.706 | 0 | ||
Other Current Liabilities, Total | 0 | 20.193 | 1.787 | 0.505 | |
Total Liabilities | 45.397 | 43.601 | 34.963 | 65.3 | 45.102 |
Total Long Term Debt | 0 | 0 | 0.682 | 8.414 | 15 |
Long Term Debt | 0 | 0.682 | 8.414 | 15 | |
Minority Interest | 0 | -0.047 | 0.019 | ||
Other Liabilities, Total | 22.266 | 23.788 | 2.02 | 30.215 | 20.887 |
Total Equity | 180.339 | 210.821 | 209.974 | -55.964 | -28.465 |
Redeemable Preferred Stock | 0 | 0 | 89.345 | 89.345 | |
Common Stock | 0.005 | 0.004 | 0.003 | 0.75 | 0.75 |
Additional Paid-In Capital | 473.135 | 397.136 | 300.888 | 2.295 | 0 |
Retained Earnings (Accumulated Deficit) | -292.801 | -186.319 | -90.917 | -148.354 | -118.56 |
Total Liabilities & Shareholders’ Equity | 225.736 | 254.422 | 244.937 | 9.336 | 16.637 |
Total Common Shares Outstanding | 47.5481 | 37.2913 | 33.6636 | 32.0886 | 32.0886 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 199.717 | 220.431 | 183.309 | 207.197 | 224.019 |
现金和短期投资 | 192.687 | 215.507 | 178.12 | 202.29 | 219.428 |
现金等价物 | 192.687 | 215.507 | 178.12 | 202.29 | 219.428 |
Prepaid Expenses | 7.03 | 4.924 | 5.189 | 4.907 | 4.591 |
Total Assets | 204.552 | 225.736 | 189.112 | 213.496 | 230.653 |
Property/Plant/Equipment, Total - Net | 4.681 | 5.151 | 5.649 | 6.144 | 6.48 |
Property/Plant/Equipment, Total - Gross | 10.339 | 10.515 | 10.791 | 10.991 | 11.041 |
Accumulated Depreciation, Total | -5.658 | -5.364 | -5.142 | -4.847 | -4.561 |
Other Long Term Assets, Total | 0.154 | 0.154 | 0.154 | 0.155 | 0.154 |
Total Current Liabilities | 26.256 | 23.131 | 23.825 | 25.507 | 17.186 |
Accounts Payable | 8.054 | 4.231 | 3.696 | 4.822 | 1.199 |
Payable/Accrued | 15.367 | 13.928 | 15.652 | 17.377 | 13.518 |
Accrued Expenses | 2.835 | 4.972 | 4.477 | 3.308 | 2.469 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | |||||
Total Liabilities | 48.125 | 45.397 | 46.478 | 48.544 | 40.6 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | |||||
Other Liabilities, Total | 21.869 | 22.266 | 22.653 | 23.037 | 23.414 |
Total Equity | 156.427 | 180.339 | 142.634 | 164.952 | 190.053 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 476.683 | 473.135 | 407.888 | 404.427 | 400.622 |
Retained Earnings (Accumulated Deficit) | -320.261 | -292.801 | -265.258 | -239.479 | -210.573 |
Total Liabilities & Shareholders’ Equity | 204.552 | 225.736 | 189.112 | 213.496 | 230.653 |
Total Common Shares Outstanding | 47.6373 | 47.5481 | 37.5773 | 37.4855 | 37.3833 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -106.482 | -95.402 | -35.853 | -29.855 | -28.979 |
经营活动产生的现金 | -90.42 | -62.214 | -36.334 | -9.645 | -35.317 |
经营活动产生的现金 | 1.199 | 1.33 | 1.008 | 0.86 | 0.794 |
非现金物品 | 14.576 | 24.434 | 1.873 | -4.476 | 3.519 |
营运资金的变化 | 0.287 | 7.424 | -3.362 | 23.826 | -10.651 |
投资活动产生的现金 | -0.265 | -0.924 | -0.59 | -1.509 | -0.988 |
资本支出 | -0.268 | -0.924 | -0.59 | -1.509 | -0.988 |
融资活动产生的现金 | 61.213 | 69.512 | 271.825 | 3.995 | 5.019 |
融资现金流项目 | -0.758 | -1.911 | 200.21 | -0.005 | 0.019 |
股票的发行(报废),净额 | 61.971 | 71.423 | 68.183 | 0 | 0 |
债务的发行(退还),净额 | 0 | 3.432 | 4 | 5 | |
现金净变化 | -29.472 | 6.374 | 234.901 | -7.159 | -31.286 |
其他投资现金流量项目,总计 | 0.003 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -27.46 | -106.482 | -78.939 | -53.16 | -24.254 |
Cash From Operating Activities | -22.654 | -90.42 | -66.073 | -42.057 | -25.136 |
Cash From Operating Activities | 0.293 | 1.199 | 0.901 | 0.601 | 0.313 |
Non-Cash Items | 3.614 | 14.576 | 11.068 | 7.48 | 3.632 |
Changes in Working Capital | 0.899 | 0.287 | 0.897 | 3.022 | -4.827 |
Cash From Investing Activities | -0.05 | -0.265 | -0.234 | -0.176 | -0.01 |
Capital Expenditures | -0.05 | -0.268 | -0.237 | -0.179 | -0.01 |
Cash From Financing Activities | -0.116 | 61.213 | -0.552 | -0.456 | -0.405 |
Financing Cash Flow Items | -0.116 | -0.758 | -0.571 | -0.475 | -0.405 |
Issuance (Retirement) of Debt, Net | |||||
Net Change in Cash | -22.82 | -29.472 | -66.859 | -42.689 | -25.551 |
Issuance (Retirement) of Stock, Net | 61.971 | 0.019 | 0.019 | ||
Other Investing Cash Flow Items, Total | 0.003 | 0.003 | 0.003 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Soleus Capital Management, L.P. | Hedge Fund | 9.0653 | 4321197 | 100800 | 2023-03-31 | HIGH |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 8.0999 | 3861000 | 3528628 | 2023-03-31 | LOW |
Tang Capital Management, LLC | Hedge Fund | 7.6028 | 3624076 | 500000 | 2023-03-31 | MED |
Short (Jay M) | Individual Investor | 6.3894 | 3045673 | -2888 | 2023-04-30 | LOW |
Acorn Bioventures L.P. | Venture Capital | 5.7197 | 2726455 | 2726455 | 2023-04-20 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.035 | 1923375 | -7664 | 2023-03-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 3.9125 | 1865000 | 201095 | 2023-03-31 | MED |
Adage Capital Management, L.P. | Hedge Fund | 3.346 | 1594942 | -155058 | 2023-03-31 | LOW |
Candriam Belgium S.A. | Investment Advisor/Hedge Fund | 3.284 | 1565406 | -240000 | 2023-03-31 | LOW |
Candriam Luxembourg S.A. | Investment Advisor | 3.1217 | 1488059 | -240000 | 2023-03-31 | HIGH |
HBM Healthcare Investments (Cayman) Ltd. | Corporation | 2.9943 | 1427317 | -1263552 | 2021-12-31 | LOW |
Pfizer Inc | Corporation | 2.8784 | 1372052 | -866038 | 2021-12-31 | MED |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 2.6604 | 1268169 | 689193 | 2023-03-31 | LOW |
Cormorant Asset Management, LP | Hedge Fund | 2.4778 | 1181115 | 0 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.7485 | 833461 | -33987 | 2023-03-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.6092 | 767082 | 110800 | 2023-03-31 | LOW |
Boxer Capital, L.L.C. | Hedge Fund | 1.4399 | 686347 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.3569 | 646781 | 8589 | 2023-03-31 | HIGH |
Vivo Capital, LLC | Venture Capital | 1.3367 | 637181 | 0 | 2023-03-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 1.264 | 602500 | -657500 | 2023-03-31 | HIGH |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BioAtla, Inc. Company profile
关于 BioAtla Inc.
BioAtla, Inc.是一家处于临床阶段的生物制药公司。 公司专注于开发用于治疗实体瘤癌症的抗体疗法。 其候选产品包括BA3011、BA3021、BA3071。 其主要候选产品BA3011是一种针对AXL的条件活性生物制剂(CAB)抗体-药物结合物(ADC)。其第二个候选产品BA3021是一种针对ROR2的CAB ADC。 其第三个候选产品BA3071是一种CAB抗CTLA-4抗体。 公司还利用其CAB技术开发双特异性抗体,这种抗体利用CAB抗原结合域同时结合肿瘤特异性抗原和T细胞受体。 其双特异性候选产品包括BA3182、BA3142、EGFR和Nectin-4。
Industry: | Biotechnology & Medical Research (NEC) |
11085 Torreyana Road
SAN DIEGO
CALIFORNIA 92121
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球530,000万多名交易者的一份子,选择利用Capital.com进行交易吧。